BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34350560)

  • 1. Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.
    Jin L; Youngblood MW; Gupte TP; Vetsa S; Nadar A; Barak T; Yalcin K; Aguilera SM; Mishra-Gorur K; Blondin NA; Gorelick E; Omay SB; Pointdujour-Lim R; Judson BL; Alperovich M; Aboian MS; McGuone D; Gunel M; Erson-Omay Z; Fulbright RK; Moliterno J
    J Neurooncol; 2021 Sep; 154(2):237-246. PubMed ID: 34350560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Prognostic Analysis of Osteolytic and Hyperostosis Sphenoid Orbital Meningiomas: A Single-Center Experience.
    He H; Li M; Luo L; Guo Y; Li W
    J Craniofac Surg; 2023 Jul-Aug 01; 34(5):1439-1443. PubMed ID: 37218028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of Endoscopic Transorbital Approach and Extended Mini-Pterional Approach for Sphenoid Wing Meningiomas with Osseous Involvement: Preliminary Surgical Results.
    Park HH; Yoo J; Yun IS; Hong CK
    World Neurosurg; 2020 Jul; 139():e1-e12. PubMed ID: 32001400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma and Bone Hyperostosis: Expression of Bone Stimulating Factors and Review of the Literature.
    Di Cristofori A; Del Bene M; Locatelli M; Boggio F; Ercoli G; Ferrero S; Del Gobbo A
    World Neurosurg; 2018 Jul; 115():e774-e781. PubMed ID: 29729471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the optic canal invasion and visual outcome in spheno-orbital meningiomas.
    Mariniello G; Bonavolontà G; Tranfa F; Maiuri F
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1615-20. PubMed ID: 23477706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphenoid wing meningiomas with osseous involvement.
    Roser F; Nakamura M; Jacobs C; Vorkapic P; Samii M
    Surg Neurol; 2005 Jul; 64(1):37-43; discussion 43. PubMed ID: 15993178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spheno-Orbital Meningiomas.
    Rawanduzy CA; Budohoski KP; Rennert RC; Winkler-Schwartz A; Couldwell WT
    Neurosurg Clin N Am; 2023 Jul; 34(3):417-423. PubMed ID: 37210130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of meningioma molecular subgroup and tumor recurrence.
    Youngblood MW; Miyagishima DF; Jin L; Gupte T; Li C; Duran D; Montejo JD; Zhao A; Sheth A; Tyrtova E; Özduman K; Iacoangeli F; Peyre M; Boetto J; Pease M; Avşar T; Huttner A; Bilguvar K; Kilic T; Pamir MN; Amankulor N; Kalamarides M; Erson-Omay EZ; Günel M; Moliterno J
    Neuro Oncol; 2021 May; 23(5):783-794. PubMed ID: 33068421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does bony hyperostosis in intracranial meningioma signify tumor invasion? A radio-pathologic study.
    Goyal N; Kakkar A; Sarkar C; Agrawal D
    Neurol India; 2012; 60(1):50-4. PubMed ID: 22406780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of bone-invasive, hyperostotic sphenoid wing meningiomas.
    Bikmaz K; Mrak R; Al-Mefty O
    J Neurosurg; 2007 Nov; 107(5):905-12. PubMed ID: 17977259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
    Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
    J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphenoid wing meningioma en plaque: report of 37 cases.
    Li Y; Shi JT; An YZ; Zhang TM; Fu JD; Zhang JL; Zhao JZ
    Chin Med J (Engl); 2009 Oct; 122(20):2423-7. PubMed ID: 20079153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperostosis in meningiomas: MR findings in patients with recurrent meningioma of the sphenoid wings.
    Terstegge K; Schörner W; Henkes H; Heye N; Hosten N; Lanksch WR
    AJNR Am J Neuroradiol; 1994 Mar; 15(3):555-60. PubMed ID: 8197957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases.
    Almeida JP; Omay SB; Shetty SR; Chen YN; Ruiz-Treviño AS; Liang B; Anand VK; Levine B; Schwartz TH
    J Neurosurg; 2018 Jun; 128(6):1885-1895. PubMed ID: 28862553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
    Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
    Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors.
    Ruzevick J; Gibson A; Tatman P; Emerson S; Ferreira M
    J Clin Neurosci; 2021 Sep; 91():105-109. PubMed ID: 34373013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
    Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M
    Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral sphenoid wing meningiomas without bone invasion-still skull base surgery?
    Corniola MV; Lemée JM; Schaller K; Meling TR
    Neurosurg Rev; 2020 Dec; 43(6):1547-1553. PubMed ID: 31664581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.